InnovAge Holding Corp. (INNV) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $8.17. It has a SharesGrow Score of 29/100, indicating a weak investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of INNV = $148.66 (+1719.6% from the current price, the stock appears undervalued). Analyst consensus target is INNV = $7 (-16.8% upside).
Valuation: INNV trades at a trailing Price-to-Earnings (P/E) of -273.2 (S&P 500 average ~25).
Financials: revenue is $854M, +7.1%/yr average growth. Net income is $30M (loss), growing at -135.2%/yr. Net profit margin is -3.6% (negative). Gross margin is 68.5% (+49.1 pp trend).
Balance sheet: total debt is $101M against $235M equity (Debt-to-Equity (D/E) ratio 0.43, conservative). Current ratio is 1.07 (adequate). Debt-to-assets is 18.1%. Total assets: $557M.
Analyst outlook: 0 / 8 analysts rate INNV as buy (0%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 20/100 (Fail), Growth 40/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 70/100 (Pass), Future 16/100 (Fail), Income 10/100 (Fail).
